- Nov 5, 2009
- Lost a loved one
Info on the Phase II trial here. It is on the market already in the UK for MS spasticity. The manufacturer, GW Pharmaceuticals, is negotiating with the FDA toward a US approval, having recently obtained approval for a CBD oral solution for certain forms of epilepsy.